FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004361702> ?p ?o ?g. }

• W2004361702 endingPage "1" @default.
• W2004361702 startingPage "1" @default.
• W2004361702 abstract "In this communication, the authors discuss the issue of individualization of thyrotropin suppressive therapy in differentiated thyroid carcinoma (DTC) patients and share their views with respect to optimizing the dose of levothyroxine (LT) prescription both during discharge from radioiodine therapy ward and during follow-up. The changing management paradigm at our Institute during post-thyroidectomy period and during the preparation for radioiodine scan is also briefly highlighted. Five factors can be identified as important determinants for the dose individualization approach: (1) Persistence or absence of metastatic disease, (2) the risk characteristics of the patient and the tumor (3) patient's clinical profile, symptomatology, and contraindications (4) the feasibility to ensure a proper thyroid stimulating hormone TSH suppression level (depends on patient's socio-economic and educational background, the connectivity with the local physician and his expertise) (5) time period elapsed since initial diagnosis. While discussing each individual case scenario, the authors, based upon their experience in one of the busiest thyroid cancer referral centers in the country, discuss certain unaddressed points in the current guideline recommendations, deviations made and some challenges toward employing them into practice, which could be situation and center specific. In addition to these, the value of clinical examination, patient profile and detailed enquiry about clinical symptomatology by the attending physician in each follow-up visit cannot be overemphasized. According to the authors, this aspect, quite important for dose determination in an individual, is relatively underrepresented in the present guidelines. It would also be worthwhile to follow a conservative approach (till clear data emerges) in patients who have characteristics of high-risk disease, but are clinically and biochemically disease free, if no medical contraindications exist and patient tolerates the suppressive therapy well. This would be particularly applicable in the presence of aggressive histopathological variants, where, in the event of recurrence/metastasis, the disease demonstrates adverse prognosis and higher incidence of radioiodine refractoriness. At the end, certain important and noteworthy concepts pertaining to LT prescription that has definitive practical implications for the suppressive therapy in DTC patients are described." @default.
• W2004361702 created "2016-06-24" @default.
• W2004361702 creator A5054315303 @default.
• W2004361702 creator A5062180890 @default.
• W2004361702 creator A5078423889 @default.
• W2004361702 creator A5084743903 @default.
• W2004361702 creator A5086554575 @default.
• W2004361702 date "2013-01-01" @default.
• W2004361702 modified "2023-09-26" @default.
• W2004361702 title "A Logical levothyroxine dose Individualization: Optimization Approach at discharge from Radioiodine therapy ward and during follow-up in patients of Differentiated Thyroid Carcinoma: Balancing the Risk based strategy and the practical issues and challenges: Experience and Views of a large volume referral centre in India" @default.
• W2004361702 doi "https://doi.org/10.4103/0972-3919.116793" @default.
• W2004361702 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3764683" @default.
• W2004361702 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24019666" @default.
• W2004361702 hasPublicationYear "2013" @default.
• W2004361702 type Work @default.
• W2004361702 sameAs 2004361702 @default.
• W2004361702 citedByCount "0" @default.
• W2004361702 crossrefType "journal-article" @default.
• W2004361702 hasAuthorship W2004361702A5054315303 @default.
• W2004361702 hasAuthorship W2004361702A5062180890 @default.
• W2004361702 hasAuthorship W2004361702A5078423889 @default.
• W2004361702 hasAuthorship W2004361702A5084743903 @default.
• W2004361702 hasAuthorship W2004361702A5086554575 @default.
• W2004361702 hasBestOaLocation W20043617022 @default.
• W2004361702 hasConcept C121608353 @default.
• W2004361702 hasConcept C126322002 @default.
• W2004361702 hasConcept C142724271 @default.
• W2004361702 hasConcept C159110408 @default.
• W2004361702 hasConcept C177713679 @default.
• W2004361702 hasConcept C187212893 @default.
• W2004361702 hasConcept C2426938 @default.
• W2004361702 hasConcept C2775883008 @default.
• W2004361702 hasConcept C2776135927 @default.
• W2004361702 hasConcept C2777074255 @default.
• W2004361702 hasConcept C2779761222 @default.
• W2004361702 hasConcept C2780182762 @default.
• W2004361702 hasConcept C2993294228 @default.
• W2004361702 hasConcept C512399662 @default.
• W2004361702 hasConcept C526584372 @default.
• W2004361702 hasConcept C71924100 @default.
• W2004361702 hasConceptScore W2004361702C121608353 @default.
• W2004361702 hasConceptScore W2004361702C126322002 @default.
• W2004361702 hasConceptScore W2004361702C142724271 @default.
• W2004361702 hasConceptScore W2004361702C159110408 @default.
• W2004361702 hasConceptScore W2004361702C177713679 @default.
• W2004361702 hasConceptScore W2004361702C187212893 @default.
• W2004361702 hasConceptScore W2004361702C2426938 @default.
• W2004361702 hasConceptScore W2004361702C2775883008 @default.
• W2004361702 hasConceptScore W2004361702C2776135927 @default.
• W2004361702 hasConceptScore W2004361702C2777074255 @default.
• W2004361702 hasConceptScore W2004361702C2779761222 @default.
• W2004361702 hasConceptScore W2004361702C2780182762 @default.
• W2004361702 hasConceptScore W2004361702C2993294228 @default.
• W2004361702 hasConceptScore W2004361702C512399662 @default.
• W2004361702 hasConceptScore W2004361702C526584372 @default.
• W2004361702 hasConceptScore W2004361702C71924100 @default.
• W2004361702 hasIssue "1" @default.
• W2004361702 hasLocation W20043617021 @default.
• W2004361702 hasLocation W20043617022 @default.
• W2004361702 hasLocation W20043617023 @default.
• W2004361702 hasLocation W20043617024 @default.
• W2004361702 hasOpenAccess W2004361702 @default.
• W2004361702 hasPrimaryLocation W20043617021 @default.
• W2004361702 hasRelatedWork W1794660144 @default.
• W2004361702 hasRelatedWork W1929014698 @default.
• W2004361702 hasRelatedWork W2018721251 @default.
• W2004361702 hasRelatedWork W2038577055 @default.
• W2004361702 hasRelatedWork W2085144152 @default.
• W2004361702 hasRelatedWork W2085244961 @default.
• W2004361702 hasRelatedWork W2319110013 @default.
• W2004361702 hasRelatedWork W2416077913 @default.
• W2004361702 hasRelatedWork W2888016817 @default.
• W2004361702 hasRelatedWork W4285099007 @default.
• W2004361702 hasVolume "28" @default.
• W2004361702 isParatext "false" @default.
• W2004361702 isRetracted "false" @default.
• W2004361702 magId "2004361702" @default.
• W2004361702 workType "article" @default.